울금 추출물의 5-Alpha Reductase Ⅱ 활성 저해 효과

국문 초록 (Abstract)

본 연구에서는 울금(Curcuma longa L.)의 다양한 추출물을 대상으로 5-alpha reductase의 활성 저해 정도를 측정하였다. 5-Alpha reductase는 T에서 활성형 남성호르몬인 DHT로 전환을 담당하며, 전립선비대에서는 혈액에서 DHT농도가 높다. Rat의 전립선조직 균질액과 5-alpha reductase를 과발현시킨 LNCaP 세포 균질액을 대상으로 측정한 결과, 100 μg/mL의 농도에서 울금의 열수추출물(CL-HW)과 20% 에탄올추출물(CL-E20)이 5-alpha reductase 활성을 효과적으로 저해하였다. 특히 CL-HW는 100 μg/mL의 농도에서 80% 이상의 유의적 억제효과를 보였으며, CL-E20은 50 μg/mL의 농도부터 80% 이상의 감소효과를 보였다. 이 같은 결과에서 CL-HW 및 CL-E20은 5-alpha reductase의 억제활성이 있으며, 이는 전립선비대 치료소재로 개발될 수 있는 가능성이 있음을 제안한다.

다국어 초록 (Multilingual Abstract)

5-Alpha reductase Ⅱ, which converts testosterone (T) to dihydrotestosterone (DHT), is a crucial enzyme Ⅱ in benign prostatic hyperplasia. Inhibitory effects of Curcuma longa L. (CL) extracts on 5-alpha reductase Ⅱ activity were investigated in rat prostate tissue homogenates as well as LNCaP cells expressing human 5-alpha reductase Ⅱ. Hot water extract (CL-HW) of Curcuma longa L. significantly inhibited 5-alpha reductase activity by over 80% at a concentration of 100 μg/mL, whereas 20% ethanol extracts (CL-E20) of Curcuma longa L. exhibited significant inhibitory activity from 50 μg/mL. These results indicated that Curcuma longa L is a potent 5-alpha reductase Ⅱ inhibitor for benign prostatic hyperplasia treatment.

목차 (Table of Contents)

• ABSTRACT
• 서론
• 재료 및 방법
• 결과 및 고찰
• 요약
• REFERENCES

참고문헌 (Reference)

1 Shin IS, "Ursolic acid reduces prostate size and dihydrotestosterone level in a rat model of benign prostatic hyperplasia" 50 : 884-888, 2012

2 Jean-Francois Bisson, "Therapeutic Effect of ACTICOA Powder, a Cocoa Polyphenolic Extract, on Experimentally Induced Prostate Hyperplasia in Wistar-Unilever Rats" 한국식품영양과학회 10 (10): 628-635, 2007

3 Hiipakka RA, "Structure-activity relationships for inhibition of human 5alpha-reductases by polyphenols" 63 : 1165-1176, 2002

4 Jugjeet S. Ramkissoon, "Relationship Between Total Phenolic Content, Antioxidant Potential, and Antiglycation Abilities of Common Culinary Herbs and Spices" 한국식품영양과학회 15 (15): 1116-1123, 2012

5 Pais P, "Potency of a novel saw palmetto ethanol extract, SPET-085, for inhibition of 5alpha-reductase Ⅱ" 27 : 555-563, 2010

6 Ejike CE, "Inhibition of the experimental induction of benign prostatic hyperplasia: a possible role for fluted pumpkin (Telfairia occidentalis Hook f.)seeds" 87 : 218-224, 2010

7 Chandrasekaran CV, "Immune-stimulatory and anti-inflammatory activities of Curcuma longa extract and its polysaccharide fraction" 5 : 71-79, 2013

8 Chaudhary UB, "Finasteride" 6 : 873-881, 2010

9 Jang S, "Establishment of type Ⅱ 5alpha-reductase over-expressing cell line as an inhibitor screening model" 107 : 245-252, 2007

10 Wang X, "Establishment of a novel model for studying the effects of extracts of Chinese herb medicine on human type Ⅱ 5alpha-reductase in vitro" 130 : 1207-1214, 2010

11 김유나, "Effect of Phellius linteus water extract on benign prostatic hyperplasia" 한국영양학회 7 (7): 172-177, 2013

12 Gasco M, "Dose-response effect of Red Maca(Lepidium meyenii)on benign prostatic hyperplasia induced by testosterone enanthate" 4 : 460-464, 2007

13 강동일, "Current Status of 5α-Reductase Inhibitors in Prostate Disease Management" 대한비뇨기과학회 54 (54): 213-219, 2013

14 Um MY, "Curcumin attenuates diet-induced hepatic steatosis by activating AMP-activated protein kinase" 113 : 152-157, 2013

15 Stefanska B, "Curcumin ameliorates hepatic fibrosis in type 2 diabetes mellitus-insights into its mechanisms of action" 166 : 2209-2211, 2012

16 Ho JN, "Anti-obesity effect of a standardised ethanol extract from Curcuma longa L. fermented with Aspergillus oryzae in ob/ob mice and primary mouse adipocytes" 2 : 1833-1840, 2012

17 Sun J, "A review on steroidal 5α-reductase inhibitors for treatment of benign prostatic hyperplasia" 18 : 3576-3589, 2011